Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 2 |
Citigroup
C
|
+$374M |
| 3 |
Amazon
AMZN
|
+$352M |
| 4 |
XL
XL Group Ltd.
XL
|
+$284M |
| 5 |
PPG Industries
PPG
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$288M |
| 2 |
Union Pacific
UNP
|
+$283M |
| 3 |
JPMorgan Chase
JPM
|
+$238M |
| 4 |
AGN
Allergan plc
AGN
|
+$226M |
| 5 |
Archer Daniels Midland
ADM
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 8.85% |
| 2 | Financials | 7.52% |
| 3 | Industrials | 6.64% |
| 4 | Energy | 5.78% |
| 5 | Technology | 5.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBG
5126
CALL
DELISTED
Bill Barrett Corp
BBG
| $341K | ﹤0.01% |
29,900
+22,400
| +299% | +$296K |
|
|
BEBE
5127
DELISTED
Bebe Stores Inc
BEBE
| $341K | ﹤0.01% |
15,556
+14,326
| +1,165% | +$349K |
|
5128
PUT
Equifax
EFX
$21.2B
| $340K | ﹤0.01% |
4,200
+2,400
| +133% | +$186K |
|
5129
REX American Resources
REX
$1.47B
| $340K | ﹤0.01% |
32,952
-57,294
| -63% | -$634K |
|
|
TMX
5130
PUT
DELISTED
Terminix Global Holdings, Inc.
TMX
| $340K | ﹤0.01% |
18,961
+11,197
| +144% | +$187K |
|
|
MCP
5131
CALL
DELISTED
MOLYCORP INC COM STK
MCP
| $339K | ﹤0.01% |
384,600
-81,700
| -18% | -$93.8K |
|
5132
Novavax
NVAX
$1.33B
| $338K | ﹤0.01% |
2,854
-1
| -0% | -$105 |
|
5133
CALL
Open Text
OTEX
$5.94B
| $338K | ﹤0.01% |
11,600
-28,000
| -71% | -$794K |
|
|
DOOR
5134
CALL
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $338K | ﹤0.01% |
5,500
+3,300
| +150% | +$186K |
|
|
MNTA
5135
CALL
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $338K | ﹤0.01% |
28,100
+14,200
| +102% | +$162K |
|
|
RGP
5136
PUT
DELISTED
REGENCY ENERGY PARTNERS LP COMMON UTS REP LIMITED PART INTS
RGP
| $338K | ﹤0.01% |
14,100
+2,400
| +21% | +$67.9K |
|
5137
CALL
BioCryst Pharmaceuticals
BCRX
$2.49B
| $337K | ﹤0.01% |
27,700
-4,700
| -15% | -$51.9K |
|
5138
Columbia Banking Systems
COLB
$9.25B
| $337K | ﹤0.01% |
+12,190
| New | +$328K |
|
|
ISIL
5139
PUT
DELISTED
Intersil Corp
ISIL
| $337K | ﹤0.01% |
23,300
-3,400
| -13% | -$45.1K |
|
|
SIVB
5140
CALL
DELISTED
SVB Financial Group
SIVB
| $337K | ﹤0.01% |
2,900
-700
| -19% | -$76.4K |
|
5141
Bank of Montreal
BMO
$130B
| $336K | ﹤0.01% |
4,744
-8,613
| -64% | -$616K |
|
5142
Nature's Sunshine
NATR
$266M
| $336K | ﹤0.01% |
22,696
-16,692
| -42% | -$247K |
|
|
ICON
5143
DELISTED
Iconix Brand Group, Inc.
ICON
| $336K | ﹤0.01% |
996
+187
| +23% | +$70.7K |
|
5144
Innoviva
INVA
$1.53B
| $335K | ﹤0.01% |
23,673
+4,121
| +21% | +$61.9K |
|
5145
CALL
Radware
RDWR
$1.23B
| $335K | ﹤0.01% |
15,200
+11,900
| +361% | +$233K |
|
5146
PUT
Voya Financial
VOYA
$9.2B
| $335K | ﹤0.01% |
7,900
-11,500
| -59% | -$460K |
|
|
ACOR
5147
CALL
DELISTED
Acorda Therapeutics
ACOR
| $335K | ﹤0.01% |
68
-1
| -1% | -$4.29K |
|
|
GLUU
5148
PUT
DELISTED
Glu Mobile Inc.
GLUU
| $335K | ﹤0.01% |
85,800
-64,700
| -43% | -$264K |
|
|
DEL
5149
DELISTED
Deltic Timber
DEL
| $335K | ﹤0.01% |
4,899
-5,196
| -51% | -$339K |
|
|
AMRE
5150
DELISTED
AMREIT INC NEW COM STK
AMRE
| $335K | ﹤0.01% |
+12,620
| New | +$320K |
|
Similar funds
Ken Griffin's Q4 2014 Portfolio in Review
As of Q4 2014, Ken Griffin held 9,167 positions worth $102B, up 6.5% from $95.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Ken Griffin's Q4 2014 filing shows 1,076 new, 3,582 increased, 3,580 reduced and 702 closed positions. Its largest new stake was SIGMA - ALDRICH CORP: 1,469,606 shares worth $202M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $288M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 8.8% of assets, up from 7.6% a quarter earlier, followed by Financials and Industrials.
- Ken Griffin's largest Q4 2014 buy was SIGMA - ALDRICH CORP: 1,469,606 shares worth $202M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $1.04B increase.
- Ken Griffin's biggest Q4 2014 reduction was Union Pacific, cutting an estimated $283M.
- Ken Griffin fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, selling an estimated $288M.
- Ken Griffin's ten largest holdings make up 16% of its $102B portfolio in Q4 2014.
- Ken Griffin opened 1,076 new positions and closed 702 in Q4 2014.
- Ken Griffin's portfolio value rose 6.5% quarter-over-quarter to $102B.
Based on Citadel Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.